Theralase Technologies Inc. (TLT.V)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 342.96 Thousand CAD | 133.14% |
| 2022 | -1.03 Million CAD | 71.69% |
| 2021 | -3.65 Million CAD | 53.06% |
| 2020 | -7.78 Million CAD | 37.21% |
| 2019 | -12.4 Million CAD | -1099.96% |
| 2018 | -1.03 Million CAD | -307.13% |
| 2017 | -253.9 Thousand CAD | 91.45% |
| 2016 | -2.97 Million CAD | 31.58% |
| 2015 | -4.34 Million CAD | -125.8% |
| 2014 | -1.92 Million CAD | -8.76% |
| 2013 | -1.76 Million CAD | -8505.41% |
| 2012 | -20.54 Thousand CAD | 44.93% |
| 2011 | -37.29 Thousand CAD | 72.83% |
| 2010 | -137.27 Thousand CAD | 87.88% |
| 2009 | -1.13 Million CAD | -4473.44% |
| 2008 | -24.76 Thousand CAD | 95.13% |
| 2007 | -507.96 Thousand CAD | -208.61% |
| 2006 | -164.59 Thousand CAD | -1338.51% |
| 2005 | 13.29 Thousand CAD | -66.53% |
| 2004 | 39.7 Thousand CAD | -36.35% |
| 2003 | 62.38 Thousand CAD | 164.27% |
| 2002 | -97.06 Thousand CAD | 33.33% |
| 2001 | -145.59 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -87.17 Thousand CAD | -134.9% |
| 2024 Q1 | 249.82 Thousand CAD | -27.16% |
| 2023 Q1 | 86.62 Thousand CAD | 108.37% |
| 2023 FY | 342.96 Thousand CAD | 133.14% |
| 2023 Q4 | 342.96 Thousand CAD | 96.97% |
| 2023 Q3 | 174.12 Thousand CAD | 632.12% |
| 2023 Q2 | 23.78 Thousand CAD | -72.55% |
| 2022 Q2 | -968.31 Thousand CAD | 62.22% |
| 2022 Q3 | -1.96 Million CAD | -102.46% |
| 2022 FY | -1.03 Million CAD | 71.69% |
| 2022 Q1 | -2.56 Million CAD | 29.9% |
| 2022 Q4 | -1.03 Million CAD | 47.21% |
| 2021 Q1 | -6.6 Million CAD | 15.13% |
| 2021 FY | -3.65 Million CAD | 53.06% |
| 2021 Q4 | -3.65 Million CAD | 25.8% |
| 2021 Q3 | -4.92 Million CAD | 15.55% |
| 2021 Q2 | -5.83 Million CAD | 11.73% |
| 2020 Q3 | -8.68 Million CAD | 8.5% |
| 2020 Q2 | -9.49 Million CAD | 11.98% |
| 2020 Q4 | -7.78 Million CAD | 10.33% |
| 2020 Q1 | -10.78 Million CAD | 13.06% |
| 2020 FY | -7.78 Million CAD | 37.21% |
| 2019 Q2 | -966.05 Thousand CAD | 42.16% |
| 2019 Q3 | -14.81 Million CAD | -1433.93% |
| 2019 FY | -12.4 Million CAD | -1099.96% |
| 2019 Q4 | -12.4 Million CAD | 16.29% |
| 2019 Q1 | -1.67 Million CAD | -61.56% |
| 2018 Q4 | -1.03 Million CAD | -106.86% |
| 2018 FY | -1.03 Million CAD | -307.13% |
| 2018 Q1 | -29.09 Thousand CAD | 88.54% |
| 2018 Q2 | -83.47 Thousand CAD | -186.95% |
| 2018 Q3 | -499.7 Thousand CAD | -498.63% |
| 2017 Q1 | -1.59 Million CAD | 46.19% |
| 2017 Q4 | -253.9 Thousand CAD | 69.97% |
| 2017 Q2 | -932.02 Thousand CAD | 41.69% |
| 2017 FY | -253.9 Thousand CAD | 91.45% |
| 2017 Q3 | -845.37 Thousand CAD | 9.3% |
| 2016 Q4 | -2.97 Million CAD | -272.81% |
| 2016 Q2 | -2.07 Million CAD | 42.44% |
| 2016 Q1 | -3.6 Million CAD | 16.86% |
| 2016 FY | -2.97 Million CAD | 31.58% |
| 2016 Q3 | -796.71 Thousand CAD | 61.65% |
| 2015 Q2 | -7.01 Million CAD | 17.88% |
| 2015 FY | -4.34 Million CAD | -125.8% |
| 2015 Q4 | -4.34 Million CAD | 21.49% |
| 2015 Q3 | -5.52 Million CAD | 21.13% |
| 2015 Q1 | -8.53 Million CAD | -344.02% |
| 2014 Q4 | -1.92 Million CAD | 10.21% |
| 2014 FY | -1.92 Million CAD | -8.76% |
| 2014 Q1 | -957.45 Thousand CAD | 45.83% |
| 2014 Q2 | -2.8 Million CAD | -193.24% |
| 2014 Q3 | -2.14 Million CAD | 23.74% |
| 2013 Q4 | -1.76 Million CAD | -281557.17% |
| 2013 Q3 | 628.00 CAD | 101.83% |
| 2013 Q2 | -34.36 Thousand CAD | -154.15% |
| 2013 Q1 | -13.52 Thousand CAD | 34.16% |
| 2013 FY | -1.76 Million CAD | -8505.41% |
| 2012 Q4 | -20.54 Thousand CAD | -1191.82% |
| 2012 Q2 | -67.19 Thousand CAD | -794.78% |
| 2012 Q1 | -7510.00 CAD | 79.86% |
| 2012 Q3 | -1590.00 CAD | 97.63% |
| 2012 FY | -20.54 Thousand CAD | 44.93% |
| 2011 Q2 | -64.81 Thousand CAD | 85.49% |
| 2011 FY | -37.29 Thousand CAD | 72.83% |
| 2011 Q4 | -37.29 Thousand CAD | -591.38% |
| 2011 Q1 | -446.85 Thousand CAD | -225.51% |
| 2011 Q3 | 7590.00 CAD | 111.71% |
| 2010 Q4 | -137.27 Thousand CAD | 68.01% |
| 2010 Q3 | -429.12 Thousand CAD | 44.02% |
| 2010 Q1 | -1.06 Million CAD | 5.68% |
| 2010 FY | -137.27 Thousand CAD | 87.88% |
| 2010 Q2 | -766.54 Thousand CAD | 28.24% |
| 2009 Q1 | 85.88 Thousand CAD | 446.83% |
| 2009 FY | -1.13 Million CAD | -4473.44% |
| 2009 Q4 | -1.13 Million CAD | -1405.77% |
| 2009 Q3 | 86.73 Thousand CAD | 1.68% |
| 2009 Q2 | 85.3 Thousand CAD | -0.68% |
| 2008 FY | -24.76 Thousand CAD | 95.13% |
| 2008 Q1 | -468.9 Thousand CAD | 7.69% |
| 2008 Q2 | -174.46 Thousand CAD | 62.79% |
| 2008 Q3 | -21.16 Thousand CAD | 87.87% |
| 2008 Q4 | -24.76 Thousand CAD | -17.01% |
| 2007 Q1 | -46.6 Thousand CAD | 71.68% |
| 2007 FY | -507.96 Thousand CAD | -208.61% |
| 2007 Q3 | -666.6 Thousand CAD | -1662.2% |
| 2007 Q4 | -507.96 Thousand CAD | 23.8% |
| 2007 Q2 | 42.67 Thousand CAD | 191.55% |
| 2006 FY | -164.59 Thousand CAD | -1338.51% |
| 2006 Q2 | -43.02 Thousand CAD | -357.11% |
| 2006 Q3 | 1757.00 CAD | 104.08% |
| 2006 Q4 | -164.59 Thousand CAD | -9468.13% |
| 2006 Q1 | 16.73 Thousand CAD | 25.91% |
| 2005 Q3 | -14.42 Thousand CAD | -846.03% |
| 2005 Q4 | 13.29 Thousand CAD | 192.12% |
| 2005 FY | 13.29 Thousand CAD | -66.53% |
| 2005 Q1 | 54.05 Thousand CAD | 36.13% |
| 2005 Q2 | -1525.00 CAD | -102.82% |
| 2004 Q2 | -418.67 Thousand CAD | -51.93% |
| 2004 FY | 39.7 Thousand CAD | -36.35% |
| 2004 Q1 | -275.56 Thousand CAD | -541.72% |
| 2004 Q3 | -366.45 Thousand CAD | 12.47% |
| 2004 Q4 | 39.7 Thousand CAD | 110.84% |
| 2003 Q4 | 62.38 Thousand CAD | 194.34% |
| 2003 Q3 | -66.13 Thousand CAD | 16.81% |
| 2003 Q2 | -79.49 Thousand CAD | 12.28% |
| 2003 Q1 | -90.62 Thousand CAD | 6.64% |
| 2003 FY | 62.38 Thousand CAD | 164.27% |
| 2002 Q2 | -131.73 Thousand CAD | 2.23% |
| 2002 Q1 | -134.73 Thousand CAD | 0.0% |
| 2002 Q4 | -97.06 Thousand CAD | 3.1% |
| 2002 Q3 | -100.17 Thousand CAD | 23.96% |
| 2002 FY | -97.06 Thousand CAD | 33.33% |
| 2001 FY | -145.59 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.17 Million CAD | 101.887% |
| Therma Bright Inc. | -91.84 Thousand CAD | 473.413% |
| VentriPoint Diagnostics Ltd. | -1.01 Million CAD | 133.625% |